|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, CDC, CMS, FDA, HRSA, SAMHSA
|
NIMH, NICHD, NIDCD, NIEHS, NINDS
|
In accordance with the Autism Collaboration, Accountability, Research, Education, and Support (CARES) Act of 2014, the Interagency Autism Coordinating Committee (IACC), a federal advisory committee, is charged with coordinating all efforts with the Department of HHS and across member federal agencies concerning autism spectrum disorder (ASD). The committee was established in an effort to accelerate progress in ASD biomedical research and services efforts by improving coordination and communication across the Federal Government and by working in partnership with the autism community. The committee is composed of officials from many different federal agencies involved in autism research and services, as well as adults on the autism spectrum, parents and family members, advocates, researchers, and other community stakeholders. Member agencies include NIH, CDC, FDA, CMS, ACL, ACF, AHRQ, and HRSA within HHS, as well as the Department of Education, Department of Defense, and the Environmental Protection Agency. In accordance with the Autism CARES Act, the committee is charged with providing advice to the HHS Secretary regarding activities and issues related to ASD. The IACC is also tasked with developing and annually updating a strategic plan for ASD research, monitoring federal activities related to autism, and preparing an annual summary of advances in ASD research.
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NINDS, NIAID
|
Department of Homeland Security led effort to determine chemical hazards and develop Chemical Risk Threat Assessment list of priority chemicals.
|
|
Interagency Committee on Assistive Technology (ICAT)
|
Committee, Work group, Advisory group, or Task Force
|
ACL
|
NICHD
|
This committee seeks to improve research on assistive technology.
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDCD
|
A Government-wide group, the Interagency Committee on Disability Research (ICDR), meets monthly to discuss the issues related to identifying people with disabilities and coordinate research in this area.
|
|
Interagency Coordinating Committee for Newborn Screening
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
This committee makes recommendations for screening certain disorders, developing a system to adjudicate newborn screening expansion, and assist states in implementing programs to test for the recommended conditions.
|
|
Interagency Coordinating Committee on Fetal Alcohol Syndrome (ICCFASD)
|
Other
|
ACF, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIAAA, NICHD, NIDA
|
The Interagency Coordinating Committee on Fetal Alcohol Syndrome (ICCFASD) was created in October 1996 in response to recommendations of an expert committee of the Institute of Medicine that NIAAA chair an effort to coordinate Federal activities on Fetal Alcohol Syndrome (FAS) and other disorders associated with prenatal alcohol exposure. ICCFASD works to improve communication, cooperation, and collaboration among disciplines and federal agencies that address issues of health, education, developmental disability, research, justice, and social services relevant to FAS and related disorders caused by prenatal alcohol exposure. The ICCFASD meets twice a year and frequently arranges special conferences; the most recent was Oct. 31-Nov. 2, 2011 on Recognizing Alcohol-related neurodevelopmental disorder (ARND) in Primary Health Care of Children.
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIDDK, NICHD, NINDS
|
Coordinates federal efforts to understand how pituitary human growth hormone may have led to the development of Creutzfeldt - Jakob disease in participants of the National Hormone and Pituitary Program.
|
|
Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, IHS, OS, OSG, SAMHSA
|
NIDA, NIAAA
|
The Consolidated Appropriations Act of 2004 directed the Secretary of Health and Human Services (HHS) to establish the Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) and to issue an annual report summarizing all Federal agency activities related to preventing underage alcohol use. HHS made ICCPUD a standing committee to provide ongoing, high-level leadership on this issue and to serve as a mechanism for coordinating Federal efforts aimed at preventing and reducing underage drinking. The Substance Abuse and Mental Health Services Administration (SAMHSA) serves as the lead ICCPUD agency.
|
|
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)
|
Research Initiative
|
ATSDR, CDC, FDA
|
NIEHS, NCI, NEI, NIAID, NLM
|
The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) is an interagency committee of 15 Federal agencies that carries out specific duties prescribed by the ICCVAM Authorization Act, P.L. 106-545. The ICCVAM is administered by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), a component of the NIEHS. NICEATM in collaboration with ICCVAM and its international collaborators in Japan, the EU, and Canada conducts research studies to evaluate the scientific validity of proposed new safety testing methods. NICEATM and ICCVAM also conduct international scientific peer review evaluations of proposed safety methods, and forward recommendations on scientific valid methods to Federal agencies, which must adopt the proposed methods or provide a basis for not adopting it. NICEATM and ICCVAM also organize scientific workshops to evaluate the current state of the science on a wide range of toxicological and other safety endpoints.
|
|
Interagency Dual Use Outreach Working Group (IDOWG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NIAID
|
Developing strategies to educate the research community about Dual Use Research of Concern (DURC) and the DURC-related USG policies
|